News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Advitech (AVI.V) Announces Positive Preclinical Results for Wound-Healing Application



10/10/2007 2:38:41 PM

QUEBEC CITY, Oct. 10 /CNW Telbec/ - Advitech Inc. ("Advitech" or the "Corporation") (TSX Venture Exchange: AVI) today announced that two milk-derived protein extracts from its XP-828L technological platform have demonstrated wound-healing properties in an in vivo study conducted by Dr. Charles Doillon of the Oncology and Molecular Endocrinology Research Centre at the Centre Hospitalier de l'Université Laval (CHUL). Dr. Doillon is a recognized researcher in the field of wound healing and angiogenesis. The study has demonstrated that both protein extracts could significantly impact the wound-healing response, especially the formation of regenerated collagen fibre and its remodelling in wound tissue.

Read at Canada NewsWire


comments powered by Disqus
Advitech
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES